Pipeline

Applied Therapeutics leverages technological advances to target molecules and pathways with proven roles in disease biology. By applying the right science and the right development strategies, the company believes it can accelerate time from clinical development to approval, and into the hands of patients who urgently need treatment. When someone is fighting a fatal or debilitating disease for which no drugs are available, every day counts.

Applied Therapeutics is developing a pipeline of novel products that target molecules and pathways with proven roles in disease biology to address high unmet need rare diseases.

InternalPage_Swoosh-min

Aldose Reductase Inhibitors (ARI)

Aldose Reductase is an enzyme implicated in multiple metabolic diseases with high unmet medical need. Applied Therapeutics has developed a new generation of ARIs for the treatment of multiple rare diseases.

Utilizing advanced crystallography, the company has developed a unique understanding of structural changes within the enzyme active site, which has enabled functional design of new compounds to improve binding affinity and specificity. These new compounds have higher Aldose Reductase inhibitory activity and less off-target activity.

COMPOUND

MILESTONES

Aldose Reductase Franchise

govorestat

Galactosemia

govorestat

SORD Deficiency
Phase 3 12-month interim data positive

govorestat

PMM2-CDG
Phase 2 ready; Expanded Access open

AT-001

Diabetic Cardiomyopathy
Phase 3 trial completed

AT-003

Diabetic Retinopathy
Phase 1 ready

Compound

Indication

Preclinical

Phase 1

Phase 2

Phase 3

Rights

Status

Phase 3 12-month interim data positive

Phase 2 ready;
Expanded Access open

Phase 3 trial completed

MAA=Marketing Authorization Application; NDA=New Drug Application

Our Approach

Applied Therapeutics leverages technological advances to target molecules and pathways with proven roles in disease biology. By applying the right science and the right development strategies, the company believes it can accelerate time from clinical development to approval, and into the hands of patients who urgently need treatment. When someone is fighting a fatal or debilitating disease for which no drugs are available, every day counts.  

Vittorio (SORD Deficiency) and mom Jill

Get the latest news and stay up to date on Applied Therapeutics.